Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06335446
Other study ID # 011040- AT validation phase
Secondary ID PG/16/10/32016
Status Completed
Phase
First received
Last updated
Start date October 2016
Est. completion date October 2019

Study information

Verified date March 2024
Source Barts & The London NHS Trust
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Atrial fibrillation (AF) is the most common sustained heart rhythm abnormality. Its incidence is increasing partly due to the aging population and it has been referred to as a growing epidemic. AF results in irregular contractions of the heart causing unpleasant symptoms of palpitations and increasing the risk of stroke, heart failure and death. Percutaneous catheter ablation is a safe treatment option in symptomatic patients with AF. The success rate of these procedures have improved with time due to our better understanding of AF, development of new techniques and technology, and greater physician experience. However, the success rate of these procedures still only remains around 70%. This is secondary to our limited ability to find the areas that drive AF. STAR mapping is a novel mapping system that has been developed with a view of better identifying the sites that drive AF through taking into account the mechanisms of AF we have so far demonstrated. To validate this mapping system we aim to use it in patients with atrial tachycardia (AT), which is a heart rhythm abnormality of which the mechanism can be readily identified with the existing mapping systems used in clinical practice. We will demonstrate that the STAR mapping algorithm can effectively map AT.


Description:

AT is a heart rhythm that currently can be effectively mapped and ablated using existing mapping systems. The mechanism of this heart rhythm is well understood. Patients that are scheduled for a catheter ablation for AT by their Electrophysiologist will be enrolled into the study. The patient will have the procedure under local anaesthetics/sedation or general anaesthetic depending on their clinical need. During the procedure tubes will be passed into the left upper chamber of the heart through the groin. Through these tubes catheters will be used to create a geometry of the heart chamber. Following this, in half of the patients a basket catheter with 64 electrodes will be positioned in the upper chamber whilst conventional catheters will be used in the other half of the patients. The aim of this is to demonstrate that the STAR mapping can be used with multiple mapping catheters. Signals i.e. electrograms will then be collected and used with the STAR mapping algorithm. The AT will then be effectively mapped and ablated with a conventional mapping system. The STAR mapping will then be used for post processing after the case to map the AT and will be compared to the maps generated by the conventional system. This will enable validation of the STAR mapping system.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date October 2019
Est. primary completion date October 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Patients able to provide informed consent 2. Patients with AT (whether de novo or occurring post AF ablation) Exclusion Criteria: 1. Unwillingness to sign consent 2. Age <18 years old 3. Contraindications for catheter ablation procedure

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Novel mapping algorithm
Signals will be collected during the catheter ablation. These signals STAR maps will be created post procedure and these will be compared to the conventional maps used during the atrial tachycardia ablation. This will be used to validate the STAR maps created.

Locations

Country Name City State
United Kingdom Barts Heart Centre London

Sponsors (1)

Lead Sponsor Collaborator
Barts & The London NHS Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary STAR maps compared to conventional maps The STAR maps demonstrating the source of the AT correlate with the maps created by the conventional mapping system. At procedure
See also
  Status Clinical Trial Phase
Completed NCT00247351 - Prevention of Atrial Tachycardia After a Right Atriotomy N/A
Completed NCT04162249 - High Radiofrequency Power for Faster and Safer Pulmonary Veins Isolation - a Pilot Observational Study.
Recruiting NCT03209583 - ATrial Tachycardia PAcing Therapy in Congenital Heart
Recruiting NCT03750435 - Non-fluoroscopy Ablation of AF/AT N/A
Recruiting NCT05883631 - RESOLVE-AF: Clinical Evaluation of the Ablacathâ„¢ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy. N/A
Recruiting NCT05434650 - Abbott Atrial Fibrillation Post Approval Study
Recruiting NCT05014802 - Baseline Atrial Fibrosis Predicts Risk for Post-operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
Completed NCT05362656 - AutoMatic disPERsion Tagging Function Preliminary Evaluation N/A
Completed NCT05344456 - PVC Response ''Atrial Pace'' Inducing Atrial Tachycardias N/A
Not yet recruiting NCT05765565 - Comparison Between the Octaray and Pentaray Catheters in Patients Undergoing Ablation for Atrial Tachycardia. N/A
Recruiting NCT05521451 - Clinical Cohort Study - TRUST
Not yet recruiting NCT06327425 - MCG for Localization of Tachyarrhythmia's Origin N/A
Completed NCT03549806 - Stanford Cardiac Invasive Electrophysiology Novel Computer Experience
Completed NCT02451995 - Effectiveness of Ripple Mapping in Atrial Tachycardia Ablation N/A
Recruiting NCT03816033 - Cryotherapy Versus Radiofrequency Catheter Ablation Research Program N/A
Completed NCT05802576 - Study of Interference Between Oral Anticoagulants and Heparin During Ablation of Atrial Fibrillation (AF) or Left Atrial Tachycardia (GAD) by Catheter.
Completed NCT01108692 - Strategy of Early Detection and Active Management of Supraventricular Arrhythmia With Telecardiology (SETAM) N/A
Active, not recruiting NCT02374359 - Atrial Tachycardia as a Predictor of Atrial Fibrillation, Stroke and Mortality in Cryptogenic Stroke N/A
Completed NCT03151278 - Zero Fluoroscopic Ablation Versus Conventional Fluoroscopic Ablation for Right Atrial Arrhythmias N/A
Completed NCT03413150 - Modeling of Amiodarone Effect on Heart Rate Control in Critically Ill Patients With Atrial Tachyarrhythmias